Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950134-04-015501
Filing Date
2004-10-22
Accepted
2004-10-22 15:41:50
Documents
5
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM 10-K f02595a3e10vkza.htm 10-K/A 553159
2 EXHIBIT 23.3 f02595a3exv23w3.htm EX-23.3 2022
3 EXHIBIT 31.7 f02595a3exv31w7.htm EX-31.7 8710
4 EXHIBIT 31.8 f02595a3exv31w8.htm EX-31.8 8816
5 EXHIBIT 32.3 f02595a3exv32w3.htm EX-32.3 4947
  Complete submission text file 0000950134-04-015501.txt   579669
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-22570 | Film No.: 041091898
SIC: 2833 Medicinal Chemicals & Botanical Products